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ABSTRACT 
The choline analog homocholine is not acetylated ~vitro by 
choline-0-acetyltransferase (ChAT, EC 2.3. 1.6) which is solubilized 
by 100 mM sodium phosphate buffer washes of a crude vesicular frac-
tion of mouse forebrain. However, both homocholine and choline are 
acetylated by a form of ChAT which is non-ionically associated with 
a subcellular fraction of mouse forebrain containing membrane asso-
ciated organelles and occluded ACh (P4 ). Acetylation of homocholine 
by membrane associated ChAT is saturable. 4-(l-Naphthylvinyl) 
pyridine (NVP) inhibits the acetylation of both choline (60%) and 
homocholine (40%) by membrane associated ChAT but reduces the acety-
lation of only choline by soluble ChAT (76%). Choline and homocho-
line serve as competitive alternative substrates for the same mem-
brane associated ChAT whereas homocholine only acts as a competitive 
inhibitor of choline acetylation by soluble ChAT. Acetylhomocholine 
competitively inhibits the acetylation of choline by both soluble 
and membrane associated ChAT more dramatically than does the natural 
end product ACh. 
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INTRODUCTION 
According to the classical model of a cholinergic nerve ending, 
acetylcholine (ACh) is synthesized by choline-0-acetyltransferase lo-
cated in the cytoplasm of the nerve ending. ACh is then transferred 
into the synaptic vesicles where it is stored. Depolarization of 
the nerve ending stimulates the release of ACh from vesicles by a Ca++ 
dependent exocytotic process. 
Presently not all studies support the classical model. In par-
ticular, the transfer of ACh from the cytoplasm to vesicles has not 
been demonstrated (Marchbanks and Israel, 1972; Suszkiw, 1976; Nelson 
et~., 1980). Also not all nerve ending ChAT is soluble. Some ap-
pears to be non-ionically associated with a crude vesicular fraction. 
Rec~nt studies using the choline analog homocholine suggest that 
ACh released upon depolarization may not necessarily be synthesized 
by soluble ChAT. Homocholine is similar to choline in most all as-
pects of cholinergic metabolism. However, homocholine differs from 
choline in one very important respect - it is not acetylated by sol-
uble ChAT (see lit. review), although it is acetylated by slices of 
rat cerebral cortex (Boksa and Collier, 1980). Therefore the objec-
tive of this study was to determine if an alternative form of ChAT, 
which is non-ionically associated with a crude vesicular fraction, 
can acetylate homocholine. 
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LITERATURE REVIEW 
Historical 
Acetylcholine (ACh) is a neurotransmitter at autonomic ganglia, the 
neuromuscular junction, at parasympathetic and some sympathetic neuro-
effector junctions, and a putative neurotransmitter in the central ner-
vous system. Katz and his associates (Fatt and Katz, 1951, 1952, 1953; 
del Castillo and Katz, 1954) presented evidence that neurotransmitter 
released spontaneously from nerve endings of the neuromuscular junction 
(ACh) in multi-molecular quanta generates post-synaptic miniature end-
plate potentials (m.e.p.p.s.). Nerve stimulation increases the fre-
qucy of m.e.p.p.s. Later, several investigators (e.g. Palade and 
Palay, 1954; deRobertis and Bennett, 1954, 1955) reported that elec-
tron microscopy revealed the presence of large numbers of spherical 
organelles ("synaptic vesicles 11 ) contained within nerve endings. These 
synaptic vesicles were considered to be the morphological correlates 
of the multi-molecular quanta reported earlier. The demonstration of 
quantal release of neurotransmitter, and the observation of synaptic 
vesicles in nerve endings led to the formulation of the vesicle hypo-
thesis (first described by del Castillo and Katz, 1957). According 
to this hypothesis, ACh which is stored in synaptic vesicles is re-
leased into the synaptic cleft upon nerve stimulation, or depolari-
zation, by a Ca++ dependent exocytotic process. Birks and Macintosh 
I (1961) demonstrated that the sympathetic gangkion contains several ~ 
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pools of ACh. One pool, known as "stationary" ACh (approximately 15% 
of the total ACh content of the ganglion) was thought to be contained 
within nerve axons and cell bodies, and remains unaltered upon nerve 
stimulation. The other pool (remaining 85% of total ACh), termed 
"depot" ACh, was thought to be present in nerve endings, and was at 
least partially releasable upon depolarization. These authors noted 
that this latter pool seemed to be made up of two subfractions, one 
of which is smaller than the other and more readily releasable upon 
depolarization. In 1962, Gray and Whittaker isolated nerve ending 
particles with synaptic vesicles contained within them (synaptosomes) 
from homogenates of guinea-pig brain. Hebb and Whittaker (1958) also 
presented evidence suggesting that the synaptosomes contained "bound" 
ACh, which corresponds to the depot ACh of Birks and Macintosh (1961). 
In 1964, Whittaker et~· reported that hypo-osmotic rupture of synap-
tosomes released approximately 50% of the bound ACh (S3 fraction, cy-
toplasmic or labile-bound) while the other 50% remained associated 
with membrane fragments (P 3 fraction, vesicular or stable-bound). The 
stable-bound ACh was bimodally distributed in subcellular fractions 
of hypo-osmotically ruptured synaptosomes spun through a discontinu-
ous sucrose gradient: one fraction (0) was enriched in synaptic 
vesicles and the other (H) contained large membrane fragments, then 
thought to be only nondisrupted synaptosomes. Several investigators 
using j.!:!_ vivo (Chakrin ~t ~., 1972) or~ vitro (Richter and March-
banks, 197la,b; Molenaar et~., 1973) techniques, reported that after 
labelling the subcellular pools of ACh to different specific activi-
ties using the precursor labelled choline, the specific activity of 
the ACh subsequently released was considerably higher than that con-
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tained in either the cytoplasmic or vesicle-bound stores. These re-
sults indicate that newly synthesized ACh is preferentially released in 
response to nerve stimulation, and also suggest that a small subpool 
of vesicles may turn over its ACh content faster than the main vesicle 
population. Barker~! ..!l_. (1972) then demonstrated that a tail vein 
injection of labelled choline into the guinea pig led to labelling of 
ACh in the different subcellular fractions of ruptured synaptosomes of 
the cortex to different specific activities, also suggesting that dif-
ferent pools of ACh turn over at different rates. Fraction H (contain-
ing the large neuronal membrane fragments and some membrane associated 
vesicles) had the highest specific activity, and fraction D (contain-
ing monooisperse synaptic vesicles) had the lowest specific activity 
of ACh. Soluble (cytoplasmic, or labile-bound) ACh had an intermedi-
ate specific activity. 
In the early 1970s, most investigators agreed that most if not all 
of the enzyme which synthesizes ACh, choline-0-acetyltransferase (ChAT) 
is soluble within the nerve ending (see review on the subcellular lo-
cation of ChAT). Therefore, based on the experimental evidence sum-
marized thus far, and the evidence that most all ChAT is cytoplasmic, 
the classical model of the cholinergic nerve ending was developed. 
According to this model, all nerve ending ACh is synthesized by sol-
uble ChAT. ACh is then transported into vesicles where it is stored, 
until depolarization stimulates the release of ACh by exocytosis. As 
mentioned earlier, not all studies support this model. Although at-
tempted by several investigators, using vesicle fractions (Marchbanks 
and Israel, 1972; Nelson et a]_., 1980) or vesicle ghosts (Suszkiw, 
5 
1977) transfer of ACh from cytop1asm into vesicles above diffusional 
levels has never been demonstrated. 
Another alternative hypothesis presented, from studies using 
Torpedo electroplaque (see review by Israel, Dunant, and Manaranche, 
1979), was that ACh is synthesized by cytoplasmic ChAT, and may be 
released directly from the cytoplasm in response to depolarization. 
Ca++ regulates gates in the neuronal membrane through which ACh is 
thought to be released during depolarization. In this case the ves-
icles serve only as storage sites for ACh. 
The development of freeze-fracture techniques has provided evi-
dence that ACh is released from nerve ending vesicles by exocytosis. 
Heuser and Reese (1973) and Heuser et~- (1974) have observed clus-
ters of "dimples" in the presynaptic membrane in a regular array 
around "active zones." Thin sections of similar tissues reveal the 
presence of numerous vesicles clustered near electron-dense regions 
in the neuronal membrane postulated to be the active-zones of re-
lease. These investigators also found that nerve stimulation increases 
the number of dimples adjacent to the active zones. The dimples are 
thought to be vesicles in the process of merging with and collapsing 
into the neuronal membrane during exocytosis. 
Recently Katz and Mi1edi (1977) and Gorio et ~l· (1978) have pre-
sented studies suggestng that ACh may be re1eased from nerve endings 
by more than one process, as follows: 1) Ca++ dependent depolarized 
release (generating electrophysiological end plate potentials); 2) 
Ca++ dependent spontaneous re1ease (generating m.e.p.p.s.); and 3) Ca++ 
independent spontaneous release (generating background "noise," thought 
to account for approximately 90% of spontaneous release, Katz and 
Miledi, 1977). Carroll and Aspry (1980) have also presented evidence 
that these different forms of ACh release may originate from differ-
ent subcellular pools of ACh within nerve endings. The functional 
significance of these several forms of release remains to be eluci-
dated. 
Subcellular location of ChAT 
The subcellular location of ChAT was the subject of controversy 
for a number of years. Hebb and her coworkers (Hebb and Smallman, 
1956; Hebb and Whittaker, 1958) demonstrated that ChAT in brain homo-
genates is partially 11 soluble 11 and partially "particle bound." The 
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soluble ChAT is that which originates from the disrupted nerve axons 
and cell bodies, and the particle bound ChAT (which represents the ma-
jority of ChAT in brain) is that which is present in synaptosomes. 
Hypo-osmotic rupture of synaptosomes releases their contents and dif-
ferent groups of investigators isolated ChAT in different subcellular 
fractions. Whittaker and his coworkers (Whittaker, Michaelson and 
Kirkland, 1964) recovered ChAT in a soluble cytoplasmic fraction of 
ruptured synaptosomes, which is removed from the occluded ACh stores 
(vesicle fractions). deRobertis et al. (1963) found that ChAT was 
associated with a subcellular fraction which did contain occluded ACh. 
Initially the difference was attributed simply to species variations 
(Tucek, 1966 a,b). However, the work of Fonnum (1967, 1968) appeared 
to resolve the situation. He found that the subcellular location 
from which ChAT was recovered depended on the pH and ionic strength 
of the suspending medium. Positively charged ChAT binds to the nega-
tively charged membranes more readily at a low pH and low ionic 
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strength, and can be removed by washing the nerve ending fractions with 
a high ionic strength buffer. Also he found that rat and rabbit brain 
enzymes (which deRobertis studied) were much more resistant to these 
effects than guinea-pig (which Whittaker used) and pigeon enzymes. 
Fonnum concluded (1968) that at physiological pH and ionic strength 
"much if not all of the [ChAT] must be in a free form, 11 and this con-
cept has been generally accepted until recently. 
Several investigators have also attempted to establish the sub-
cellular location of ChAT using electron microscopic histochemical 
techniques. Kasa (1970, 1975), utilizing Pb capture of Coenzyme A, 
found the reaction product in the cytoplasm, and adsorbed to mito-
chondria and vesicles, but not within vesicles. However, Fiegenson 
and Barrnett (1977) using different histochemical techniques (utiliz-
ing Mn++ and ferrocyanide) found reaction product within the vesicles, 
and the appearance of the product was sensitive to inhibition by the 
ChAT inhibitor 4(1-Naphthyvinyl)pyridine (NVP). Therefore, based on 
cytochemical techniques, the subcellular location of ChAT was still 
somewhat controversial. 
ChAT from mammalian tissue can be separated into several molecu-
lar forms on the basis of isoelectric point (e.g. White and Wu, 1973,c). 
It is not presently clear which form (or forms) is (are) functionally 
significant in neurotransmission. Krell and Goldberg (1975) reported 
that the ChAT inhibitor NVP, when injected into mouse or guinea-pig, 
inhibited soluble ChAT but there was no significant alteration in 
steady state brain ACh levels. ~ven at a neutral pH and high ionic 
strength, a certain amount (20-40%) of nerve ending ChAT remains in-
soluble. Hebb (1972) has suggested that "Even if reduced to 10%, the 
enzyme remaining bound, if strategically located, could be responsible 
for the production of as much ACh as is present in the storage system, 
the 'depot' ACh of Birks and Macintosh 11 (1961). 
Recently Smith and Carroll (1980) havademonstrated that a crude 
vesicular fraction (P3) of mouse forebrain, prepared from hypo-osmo-
. tically ruptured synaptosomes, retains approximately 15% of synapto-
somal ChAT activity, after washing the fraction twice with 100 mM so-
dium phosphate buffer at a pH of 7.4. ChAT which is solubilized by the 
high ionic strength buffer washes appears to differ from the bound 
ChAT, in that it is more sensitive to inhibition by ACh and NVP, and 
is also more dependent on Na+. The fraction (P 3) which contains mem-
brane bound ChAT also contains stable bound ACh (protected from hy-
drolysis by AChE in the absence of a cholinesterase inhibitor). Also 
ACh synthesized by membrane bound ChAT is partially protected from 
hydrolysis when excess AChE is added to the incubation medium, where-
as ACh synthesized by soluble ChAT is not. This membrane bound form 
of ChAT may be functionally significant in neurotransmission. 
Substrates for ChAT 
ChAT catalyzes the synthesis of ACh from choline and acetyl CoA. 
An exogenous supply of choline is required to maintain ACh synthesis 
over a period of time since choline is not synthesized in the brain. 
The concentration of choline present in the extracellular space is 
maintained by choline from the plasma, and also choline resulting from 
the hydrolysis of ACh by acetylcholineserase present in the synaptic 
cleft. Choline may also be partially supplied by the breakdown of 
membrane lipids. Uptake of choline into nerve terminals from the 
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synaptic cleft is thought to occur by one of two transport processes: 
low-affinity transport, with a Kt of 50-100 uM, and a high-affinity 
transport, with a Kt of 1-5 uM. The latter has been postulated to be 
specific for cholinergic nerve endings (Kuhar et~., 1973), and also 
to be coupled to ACh synthesis (e.g. Barker and Mittag, 1975) (see 
reviews by Kuhar and Murrin, 1978; and Jope, 1980). 
The origin of acetyl CoA for ACh synthesis in nerve endings is 
presently unknown. It is synthesized within mitochondria; but whether 
acetyl CoA for ACh synthesis is generated at another location in the 
nerve ending, remains to be elucidated. An external source of acetate 
groups is required to maintain ACh synthesis. Several investigators 
have found glucose and pyruvate to be good precursors, both~ vivo 
(e.g. Tucek and Cheng , 1974) and~ vitro (e.g. Lefresne ~! ~., 1973; 
Guyenet et ~J_., 1973). Balfour and Hebb (1952) found that acetone 
extract powders of brain tissue are able to synthesize ACh from chol~ 
ine and either citrate or acetate. Tucek (1967 a,b,c) has reported 
that citrate-ATP lyase (EC 4. 1.3.8) and acetyl CoA synthase (EC 6.2. 1. 1) 
(which synthesize acetyl CoA from citrate and acetate, respectively) 
are at least partially extramitochondrial enzymes. Alternatively, 
Sollenburg and Sorbo (1970), and Sterling · ~dO'Neill (1978) have sug-
gested that citrate may simply mediate the transport of the acetyl 
moiety from mitochondria to the site of synthesis of ACh. Gibson and 
Shimada (1980) report that citrate may not be the only intermediate 
in acetyl CoA metaboli~m in brain tissue, but that acetate and carni-
tine may also be involved. They also present evidence that acetyl CoA 
involved in ACh synthesis may be distinguished from acetyl CoA involved 
in lipid synthesis, by using (-) hydroxycitrate and n-butylmalonate, 
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both inhibitors of citrate metabolism. This agrees with a previous 
study by Tucek and Cheng (1974) which reports that when rats were in-
jected with [l,s- 14c] citrate, the lipid stores in the brain became 
labelled, whereas ACh did not. However this last study only examined 
whole brain ACh, and did not distinguish between the different sub-
cellular pools of ACh. 
Another alternative, proposed by Tucek (1967, c) is that acetyl 
CoA may itself be .transported out of mitochondria during mitochondrial 
contractions. 
Kinetic mechanism of ChAT 
Several different mechanisms have been proposed by different 
groups of investigators on how ChAT catalyzes the synthesis of ACh. 
Kinetic studies have often led to different conclusions for several 
reasons. ChAT has not yet been isolated in pure form and often enzyme 
preparations may be contaminated with other proteins which interfere 
with the assay. Also ChAT decreases in specific activity the more it 
is purified (Hebb, 1972). Finally a variety of different species 
have been used in kinetic studies. In general, most investigators 
believe that ChAT functions by the Theorell-Chance mechanism (e.g. 
White and Wu, 1973, b; Morris et~..!_., 1971). According to this mech-
anism of enzyme activity both the reactants (choline and acetyl CoA) 
bind and the products (ACh and CoA) dissociate from the enzyme in a 
particular order. However, Hersh and Peet (1977) have suggested that 
not all experimental evidence uniquely supports this type of mechanism. 
These authors employed dead-end inhibitors and alternate substates, 
and suggest that ChAT functions by a sequential random mechanism, in 
which the substrates bind and the products dissociate in random order. 
l'l 
They indicate that product inhibition studies (in which ACh competi-
tively inhibits acetyl CoA but noncompetitively inhibits choline) can 
be also explained by the sequential random mechanism. Also, the deu-
terium isotope effect observed by Currier and Mautner (1974) (inter-
preted as general base catalysis) is not consistent with the Theorel l -
Chance mechanism. 
Several investigators have attempted to classify ChAT as a sulf-
hydryl enzyme (i.e., the enzyme requires a free sulfhydryl group in 
its active site) utilizing various sulfhydryl agents (e.g. Reisburg, 
1957; Mannervik and Sorbo, 1970). In general most investigators now 
agree that ChAT contains "nonessential" sulfhydryl groups, and that 
inhibition of ChAT by sulfhydryl reagents may be caused by conforma-
tional changes in the enzyme, and not by direct binding to the ac-
tive site (e.g. White and Cavallito, 1970; see also review by Hebb, 
1972). 
Imidazole (or histidine) residues have -also been implicated by 
Currier and Mautner (1974) among others (e.g. White and Cavallito, 
1970), particularly in view of the previously mentioned general base 
catalysis observed by these authors. Imidazole groups have been 
shown to activate ChAT (White and Cavallito, 1970; Hebb et 2-}_., 1975; 
Davies, 1979) and may also synthesize ACh nonenzymatically (Burt and 
Silver, 1973; Aquilonius and Eckernas, 1976). 
Ionic requirements of ChAT h-ave also been studied by several 
groups of investigators. Rossier ~! 2-}_. (1977) demonstrated that only 
Cl activates ChAT solubilized from rat brain. However, Hersh (1980) 
found that all monovalent anions activate ChAT to the same extent. 
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Guyenet et~- (1973) and Smith and Carroll (1980) have found that 
ChAT is dependent on Na+ for activity. · Additionally, Hersh and his 
coworkers (1978, a,b,c) demonstrated that enzyme activity and mecha-
nism · may be regulated by ionic strength, and that divalent cations 
h C ++ d ++ . h"b"t th sue as a an Mg in i i e enzyme. 
Studies using homocholine 
Recent results obtained with the choline analog homocholine (3-tri-
methylamino propan-1-ol) support the possibility that the activity of 
soluble ChAT may not be essential to the formation of transmitter re-
leased during depolarization (Collier et~., 1977). The structure of 
homocholine is shown in Fig. 1. Homocholine is similar to choline in 
many aspects of cholinergic metabolism. It is transported into rat 
brain synaptosomes (Collier et ~_l., 1977) and el ectroplaques of 
Torpedo (van Schwarzenfeld ~!. ~., 1979; Luqmani et 2.l·, 1980) and is 
acetylated and released as acetylhomocholine (AHCh) from the superior 
cervical ganglion (Collier et 2.l·, 1977), guinea-pig cortex (von 
Schwarzenfeld, 1979), Torpedo electroplaques (Luqmani et~., 1980) 
++ 
and minces of mouse forebrain (Carroll and Aspry, 1980) by a Ca de-
pendent process during depolarization. A crude vesicular (P 3) frac-
tion of mouse forebrain, depleted of its acetylcholine content inde-
pendently of the cytoplasm (S3) by incubation of mouse forebrain 
minces in a lithium-high potassium Krebs medium, can also be refilled 
with either newly synthesized AHCh or new ly synthesized ACh formed 
from their respective precursors homocholine or choline. This refill-
ing does not occur by transfer of the acetylate rl product from the s3 
fraction since the ratio of newly synthesized to preformed transmitter 
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in the P3 fraction exceeds that of the s3 fraction (Carroll and Nelson, 
1978; Nelson et~., 1980). 
Homocholine, however, differs from choline in one very important 
respect. Homocholine is not acetylated by soluble ChAT (Burgen et~., 
1956; Dauterman and Mehrotra, 1963; Currier and Mautner, 1974; Barker 
and Mittag, 1975; Collier~.!~., 1977). Therefore the objective of 
this investigation was to determine if homocholine is acetylated by 
the membrane associated form of ChAT present in the nerve endings of 
mouse forebrain. 
14 
MATERIALS AND METHODS 
Choline and 3-heptanone (practical grade) were obtained from 
Eastman Company (Rochester, NY) and the 3-heptanone was redistilled 
(collected at 146-147°C). Eserine sulfate and carnitine were pur-
chased from Sigma Chemical Company (St. Louis, MO) and 4-(1-naphthyl-
vinyl) pyridine (NVP) and acetyl Coenzyme A from Calbiochem (La 
Jolla, CA). Sodium tetraphenylboron and toluene (spectanalyzed) 
were purchased from Fisher Scientific Company (Fairlawn, NJ). Aquasol 
II, Hyamine hydroxide, Liquifluor, [acetyl-l-14c] acetyl Coenzyme A 
(spec. act. 48.3 mCi/mmol), [ 14c] methyl iodide (spec. act. 31.0 
mCi/mmol) and [14c] acetylcholine (spec. act. 1.2 mCi/mmol) were pur-
chased from New England Nuclear (Boston, MA). Homocholine, acetyl-
homocholine, [ 14c] homocholine and [ 14c] acetylhomocholine, were syn-
thesized as described by Nelson et ~J_. (1980). 
Enzyme preparations 
Male CD-1 albino mice were killed by cervical dislocation, the 
forebrains quickly removed and placed into ice-cold Normal Krebs (com-
position in mM; NaCl, 117; KCl, 3.5; MgS04, 1.2; NaHC03, 28.0; KH 2Po4, 
1.2; CaC1 2, 2.5; Glucose, 11.0). They were blotted dry, weighed, 
minced, and incubated for 15 min in Normal Krebs at 38°C. Minces 
were then washed twice with ice-cold 0.32 M sucrose, and subcellular 
fractions prepared according to the method of Gray and Whittaker (1962), 
as modified by Collier et~· (1972) and Salehmoghaddam and Collier 
(1976). Minces were homogenized in 5.0 ml of 0.32 M sucrose at 840 
15 
rpm with 8 up and down strokes. This homogenate was spun at 1000 g 
for 10 min, and the supernatant spun at 17,000 g for 15 min, to yield 
a P2 (synaptosomal) pellet. Synaptosomes were hypo-osmotically rup-
tured by homogenizing the P2 pellet in 2.0 ml of water at 400 rpm us-
ing 8 up and down strokes. This homogenate was spun at 100,000 g for 
60 min to yield a crude vesicular fraction (P 3) and an s3 fraction 
believed to contain soluble cytoplasmic contents. The s3 fraction was 
discarded. The P3 fraction, which contains occluded ACh, was then 
washed twice with 1.0 ml of 100 mM sodium phosphate buffer (pH 7.4) 
in order to remove ionically bound ChAT (Fonnum, 1968). Approximate-
ly 703 of the ChAT activity recovered from the hypo-osmotically rup-
tured P2 fraction was present in the 100 mM sodium phosphate buffer 
wash of the P3 fraction whereas 15% remained in the washed P3 (Smith 
and Carroll, 1980). The washed P3 fraction was then homogenized in 
1.0 ml of water and layered on top of a discontinuous sucrose gradi-
ent containing 2 ml each of 0.4 M and 0.6 M sucrose and spun at 
192,000 g for 30 min. The pellet was homogenized in 500 ul of water 
and stored at -20°C until determinat i on of ChAT activity. The 0.4 M 
sucrnse layer was pelleted at 100,000 g for 60 min. This fraction 
was suspended in 200 ul of water for enzyme assay. The 0.6 M frac-
tion was also pelleted at 100,000 g for 60 min and suspended in 500 ul 
of water for enzyme assay. P4, 0.4 Mand 0.6 M fractions were never 
kept for more than 7 days, and the solubilized enzyme never more than 
2 days, since it was noted that enzyme activity declined after these 
times even though stored at -20°C. In one set of experiments, the P4 
fraction was washed with 1.0 ml of 100 mM sodium phosphate buffer, 
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centrifuged at 100,000 g for 60 min and the ChAT activity determined 
in the wash fraction as well as the washed P4 fraction. 
Enzyme assays 
ChAT activity in the various fraction was determined in duplicate 
or triplicate by the method of McCamen and Hunt (1965) as modified by 
Fonnum (1969). Aliquots of 2 ul of the tissue fractions or the pooled 
sodium phosphate buffer washes of the P3 fraction were incubated for 
varying time periods (activity was linear for at least 30 min for all 
substrate concentrations used) at 39°C, a temperature which activates 
brain ChAT activity (Hebb, 1975), with 20 ul of a buffer substrate 
consisting of the following components: NaCl (234 mM), Bovine Plasma 
Albumin (0.0375%), MgC1 2 (17mM), sodium phosphate buffer, pH 7.4 
(84 mM), Eserine (150 uM), [ 14c] acetyl Coenzyme A (343 uM, spec. act. 
2 mCi/mmol) and one or several of the following substrates in the 
concentrations indicated: choline, homocholine, carnitine, or no 
added substrate. Acetyl CoA: Carnitine-0-acetyltransferase (carnitine 
acetyltransferase, EC 2.3. 1.7) activity was determined by replacing 
choline with carnitine in the McCamen and Hunt assay. In some experi-
ments the following compounds were tested as inhibitors of ChAT: ACh, 
AHCh, and NVP. Stock solutions were prepared fresh in water (pH 4.0 
for ACh and AHCh) and l ul aliquots were added to tissue samples just 
prior to addition of the buffer substrates. One ul of water (pH 4.0) 
did not affect soluble or membrane bound ChAT activity. NVP solu-
tions were always prepared in amber bottles and the assay conducted 
in a darkened room, since NVP is light sensitive. 
Following incubation, samples were chilled and the acetylated 
products were extracted with 150 ul of sodium tetraphenylboron/ 
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3-heptanone (TPB/3-hept., 75 mg/ml). One ml of Hyamine hydroxide was 
14 
added to 100 ul of the TPB/3-hept. extract and [ CJ acetylated pro-
ducts were counted in 15 ml of toluene containing Liquifluor. Acetyla-
tion was calculated from the specific activity of the buffer substrate, 
which was counted in the presence of TPB/3-hept. (75 mg/ml) (extrac-
tion of acetylated products into 75 mg/ml TPB/3-hept. was essentially 
complete). Net acetylation was corrected for acetylation of endogen-
ous substrates. Because of variability in the tissue preparation, all 
experiments were conducted on forebrains from at least 6 experimental 
animals except where indicated. 
Chromatography 
Tissue aliquots were incubated as;previously described except that 
acetylated products were extracted with 5 mg/ml TPB/3-hept. 100 ul 
of the organic phase was mixed with 50 ul lN HCl and aliquots of the 
HCl pooled and dried. Two ul of water was added to the dried extract 
and the sample was streaked on a strip of Whatman #3 paper . Acety~ -
lated products were separated by descending paper chromatography in a 
solvent system of n-butanol: ethanol:lN acetic acid: water (8:2:1:3) 
and identified by comparison with [ 14c] ACh and [ 14c] AHCh standards 
run simultaneously. Labelled products were dissolved from 1 cm strips 
in l ml of water and counted in Aquasol II. 
Electron microscopy 
Pellets obtained from the subcellular fractionation were fixed 
in 1% formaldehyde in 50mM cacodylate buffer, and post-fixed in 1% 
Oso4 in Millonig's phosphate buffer. They were then dehydrated in 
ethanol and embedded in Spurr's resin according to standard procedures 
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(Spurr, 1969). Ultra-thin sections were stained with lead citrate and 
uranyl acetate, and examined under an RCA EMU-3F electron microscope . 
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RESULTS 
Recovery of P3 ChAT activity following sucrose density gradient cen-
trifugation. 
Aliquots of the subcellular fractions of mouse forebrain were as-
sayed for ChAT activity using 10 mM choline. ChAT which is nonionical-
ly bound to the P3 fraction, i.e., ChAT which remains associated with 
that fraction after two washes with 100 mM sodium phosphate buffer 
(pH 7.4), formed 429.7_2: 71.4 nmol/g wet wt/hr of acetylated product 
(n=4). Approximately 81% of the ChAT activity associated with the 
washed P3 fraction was recovered from the 3 fractions of the sucrose 
density gradient: the 0.4 M sucrose fraction formed 9.0_:2.5 runol/g 
wet wt/hr (n=24) and electron microscopy revealed that this fraction 
is enriched with spherical organelles resembling vesicles; the 0.6 M 
sucrose fraction formed 48.5_:14.9 nmol/g wet wt/hr (n=6); and the P4 
fraction formed 289_2:61 nmol/g wet wt/hr (n=18). Electron micrographs 
of this fraction revealed that it contains large membrane fragments, 
which have spherical organelles associated with some fragments, simi-
lar to those shown in a recent report (von Schwarzenfeld, 1978). In 
the experiment in which the P4 fraction was homogenized in 1.0 ml of 
100 mM sodium phosphate buffer (pH 7.4), centrifuged, and its ChAT 
activity compared with an unwashed P4 fraction, the ChAT activity was 
identical (353.4_:37.4 vs. 362.4_2:14.9 nmol/g wet wt/hr, n=3). ChAT 
activity in the 100 mM sodium phosphate buffer wash of the P4 fraction 
was not detectable. The P4 fraction, which also contains occluded 
ACh (Carroll and Benishin, 1~79) most closely reflects the metabolic 
activity of the P3, a conclusion supported by a recent publication in 
which Torpedo electroplaques were studied (Luqmani ~! ~., 1980). 
Therefore, this fraction was selected for the subsequent kinetic ana-
lyses. 
Kinetics of homocholine acetylation by the P4 fraction. 
The kinetic parameters for P4 ChAT activity as a function of added 
homocholine were determined using substrate concentrations ranging 
-5 -2 from 10 to 10 M. Each point represents the average velocity, cor-
rected for acetylation of endogenous substrates, for 15 forebrains. 
Results in Figure 2 indicate that the apparent Km value for homocholine 
acetylation is 49 uM, and the apparent Vmax for homocholine acetylation 
is 70 nmol/g wet wt/hr. Boiling tissue prior to incubation with homo-
choline (10 mM, n=6) reduced the formation of acetylated products to 
the level of tissue-free blanks. 
Ability of NVP to inhibit choline and homocholine acetylation by the 
P4 fraction. 
Several reports have suggested that carnitine acetyltransferase, 
which is present in cholinergic preparations, may acetylate choliner-
gic neurotransmitter precursors (White and Wu, 1973a; Tucek et~., 
1978). To determine if choline and/or homocholine are primarily 
acetylated by P4 ChAT rather than carnitine acetyltransferase, ali-
quots of the P4 fraction were incubated either in the presence or ab-
sence of NVP, which inhibits ChAT but not carnitine acetyltransfer-
ase (White and Wu, 1973a). Results shown in Fig. 3 indicate that NVP 
21 
(4.6 uM) significantly reduces acetylation of choline (60%) and homo-
choline (40%), but stimulates acetylation of carnitine (18%) by the 
P4 fraction. 
Jnability of NVP to reduce acetylation of homocholine by solubilized 
ChAT. 
Results presented in Table 1 indicate that NVP (4.6 uM) signifi-
cantly reduces choline acetylation by ChAT solubilized from the P3 
fraction 76%. This fraction acetylates carnitine and homocholine very 
poorly, and NVP does not alter acetylation of either substrate. 
Does homocholine serve as a competitive alternative substrate to cho-
line for acetylation by P4 ChAT? 
Results obtained in this study with the ChAT inhibitor NVP sug-
gest that both choline and homocholine are acetylated by ChAT in the 
P4 fraction. To determine if both substrates are acetylated by the 
same or different forms of ChAT in the P4 fraction, the kinetic para-
meters of choline acetylation were determined in the absence or pre-
sence of several fixed homocholine concentrations (0.5, 1.0, 5.0, or 
10.0 mM) using 3 forebrains, according to the procedure of Ch.a (1968). 
In this method, two potential substrates are simultaneously incubated 
with the enzyme and the concentration of one substrate, A, is varied 
while the other, B, is held constant, and the combined velocity of 
products formed is determined. In the present experiments, the com-
bined velocity equals the total amount of acetylated products formed, 
i.e., [14c] ACh and [ 14c] AHCh. Both of these products behave 
identically in the assay used and are extracted equally by TPB/3-hept. 
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When both substrates are metabolized by the same enzyme and substrate 
A is better than B (i.e., the Vmax for A exceeds t he V'max for B), then 
a plot of l/v (combined velocity) vs. l/[A] will be hyperb·0lic. When 
a series of kinetic plots are generated using different fixed levels 
of substrate B or in the absence of B, and Vmax exceeds V'max' then the 
curves generated will intersect at a common point. A theoretical com-
mon point of intersection can be predicted from the following relation-
ship: S= V'max· Km/(Vmax-V'max) where S represents the concentration 
of substrate A at the co1TITion point of intersection,and Km represents 
the apparent Michaelis constant obtained for substrate A. 
When the Vmax equals V'max the curves will merge at the Y axis 
and not be straight lines. If substrate B is not metabolized by the 
same enzyme as A but competes with A for binding to the same enzyme, 
then a series of straight lines is generated which yield similar Vmaxs. 
If two enzymes. are involved in the metabolism of the two substrates, 
the curves obtained will not intersect at one point. 
Figure 4 depicts the pooled results obtained for two different 
experiments where 1/v (combined velocity) vs. l/S (corrected for en-
dogenous choline concentration) for each fixed homocholine concentra-
tion (0,0.5, 1.0, 5.0, or 10.0 mM) is plotted. Values were normal-
ized by multiplying l/v by Vmax for choline and 1/S (corrected) by the 
Km for choline for each of the two experiments. The correlation coef-
ficients obtained for the least squares regression lines of the data 
points (dotted lines) decrease as the concentration of homocholine is 
increased. Polynomial regression analysis shows that a second degree 
polynomial fits the data points obtained better than a straight l i ne 
when homocholine is present. 
The combined plot (Figure 5) shows that the curves do in fact in-
tersect at one common point as predicted when one enzyme metabolizes 
both substrates. When this experiment was repeated a third time with 
another forebrain, kinetic plots yielded a similar pattern. 
Table 2 summarizes the kinetic parameters obtained for choline and 
homocholine for all three alternative substrate binding experiments. 
The Vmax for choline acetylation (295 _:: 86 nmol/g wet wt/hr) exceeds 
the V'max for homocholine acetylation (79 _:: 23 nmol/g wet wt/hr) by 
approximately 3.7 fold. The theoretical point of intersection (47 uM 
choline) is similar to the actual point of intersection obtained for 
the three experiments (52 _:: 5 choline). The mean Vmax value for homo-
choline acetylation by P4 ChAT obtained using the Cha procedure 
(79 _:: 23 nmol/g wet wt/hr, n=3) closely corresponds to the value ob-
tained for homocholine acetylation by the method of Lineweaver and 
Burk (1934) (70 nmol/g wet wt/hr, n=l5). 
Does homocholine serve as a competitive alternative substrate to cho-
line for acetylation by soluble ChAT? 
Aliquots of the sodium phosphate buffer wash of the P3 fraction 
were incubated with varying concentrations of choline in the absence 
or presence of fixed homocholine concentrations (2.0, 10.0, 20.0 mM) 
as described in the previous section for P4 ChAT. Again values were 
normalized. The plot of Vmax/v vs. Km/S for the sodium phosphate 
buffer was different (Figure 6) from that obtained for the P4 fraction. 
For example, the correlation coefficients obtained for the least 
squares regression lines do not change with increasing homocholine con-
centration and polynomial regression analysis indicates that the 
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points are best fit by straight lines rather than second degree poly-
nomials. Regression coefficients increase with increasing homocholine 
concentration and the Vmaxs for choline acetylation do not change with 
increasing homocholine concentration suggestingthat homocholine compe-
titively inhibits the binding of choline to soluble ChAT but is not 
being acetylated. 
Ability of ACh and AHCh to inhibit acetylation of choline by solubil-
ized and P4 ChAT 
ACh competitively inhibits choline acetylation by ChAT (Kaita and 
Goldberg, 1969; White and Wu, 1973 b,c; Smith and Carroll, 1980). To 
determine if AHCh also inhibits acetylation of choline by soluble and/or 
P4 ChAT, aliquots of the sodium phosphate buffer wash or P4 fraction 
were incubated in the presence or absence of varying concentrations of 
AHCh and compared with similar concentrations of ACh. To insure that 
the added inhibitor did not interfere with the extraction of labelled 
acetylated product into the TPB/3-hept., ACh or AHCh was added to 
some samples following incubation with the buffer substrate. Their re-
spective effects on the amounts of acetylated products extracted into 
TPB/3-hept. were determined to be negligible at the inhibitor concen-
tration used. 
ACh, as expected, inhibits acetylation of choline by ChAT in the 
sodium phosphate buffer wash and the P4 (Figure 7). AHCh also inhibits 
both soluble and P4 ChAT activity in a dose · dependent manner, and is 
a more potent inhibitor of both enzyme forms than is ACh. Dixon plots 
of ACh inhibition of P4 ChAT and AHCh inhibition of P4 and soluble 
ChAT indicate that inhibition is competitive in all 3 cases, as 
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illustrated in Figures 8, 9, and 10. Plots of l/v of AHCh or ACH con-
centrati on for the different concentrations of choline (1.1 and 4.3 mM) 
intersect in tht fourth quadrant, which is consistent with competitive 
inhibition, and yield Kis of 63mM, lOmM, and 200mM, respectively. 
DISCUSSION 
In agreement with the results of others (Burgen et i.!_., 1956; 
Dauterman and Mehrotra, 1963; Currier and Mautner, 1974; Collier et i.!_., 
1977), the choline analog homocholine does not appear to be acetylated 
by soluble ChAT. The ChAT inhibitor NVP (Krell and Goldberg, 1975) 
does not reduce its acetylation at a concentration which reduces cho-
line acetylation by approxi~ately 75%. It does,however, compete with 
choline for binding to soluble ChAT since its presence alters the 
kinetic plots obtained for choline acetylation in a mamersuggestive 
of competitive binding (Cha, 1968). 
Homocholine, like choline, is acetvlated by a form of ChAT which 
is nonionically associated with a fraction of mouse forebrain nerve 
endings that contains both occluded ACh and subcellular organelles 
associated with neuronal membranes (P 4). Acetylation of homocholine 
by this fraction is saturable and inhibited by the ChAT inhibitor NVP. 
Homocholine alters the kinetic plots obtained for P4 ChAT as a func-
tion of choline in a manner which suggests that both it and choline 
are acetylated by the same ChAT in the P4 fraction. Choline is a su-
perior substrate to homocholine for acetylation by ChAT in the P4 
since the Vmax value obtained for choline by the method of Lineweaver 
and Burk (1934) (295 ! 86 nmol/g wet wt/hr, n=3) exceeds the V'max 
values obtained for homocholine using either the method of Lineweaver 
and Burk (70 nmol/g wet wt/hr, n=l5) or that of Cha (79 + 23 nmol/g 
wet wt/hr, n=3) by almost 4-fold. 
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Several results obtained in the present study and a previous one 
(Smith and Carroll, 1980) indicate that membrane associated ChAT does 
not represent soluble ChAT which has become artificially associated 
with membranes during tissue preparation or soluble ChAT contained in 
nondisrupted synaptosomes. When the P4 fraction is washed with 100 
mM sodium phosphate buffer following sucrose density gradient centri-
fugation rather than suspended in distilled water, the ChAT activity 
determined in the washed and unwashed P4 fractions is identical. This 
result indicates that suspension of the P3 fraction in distilled water 
prior to sucrose density gradient centrifugation does not cause sol-
uble ChAT to bind ionically to membranes recovered in the P4 fraction. 
Addition of excess acetylcholinesterase during the initial brain homo-
genization hydrolyzes at least 90% of the ACh formed by s3 without 
hydrolyzing any ACh formed by the P3 fraction washed twice with 100 mM 
sodium phosphate buffer (pH 7.4) indicating that tissue homogenization 
does not form subcellular organelles which trap cytoplasmic ChAT. NVP 
inhibits the acetylation of homocholine by membrane bound but not sol-
uble ChAT, whereas it reduces the acetylation of choline by soluble 
ChAT to a greater extent than it reduces the acetylation of choline by 
membrane bound ChAT. If homocholine were acetylated by soluble ChAT 
contained in nondisrupted synaptosomes associated with the P4 fraction, 
then NVP should inhibit the acetylation of homocholine by soluble 
ChAT to a greater extent than it reduces acetylation of homocholine 
by the P4 fraction and it clearly does not. Homocholine competitively 
inhibits the binding of choline to soluble ChAT but is not itself 
acetylated by this form of the enzyme. Conversely, it competitively 
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inhibits the binding of choline to membrane bound ChAT and is acety-
lated. 
Results presented here appear to differ from those of Boksa and 
Collier (1980) who concluded that homocholine is probably a substrate 
for ChAT based on~ situ evidence, but were unable to demonstrate ap-
preciable acetylation of homocholine ~vitro relative to choline. 
Their investigation, in contrast to this experimental protocol, en-
couraged the association of soluble nerve ending ChAT to membranes by 
suspending ruptured synaptosomes in a low osmotic strength medium. 
Then they compared the ability of membrane associated ChAT to acetyl-
ate choline and homocholine and were unable to detect appreciable 
acetylation of homocholine relative to choline. The ability to detect 
acetylation of homocholine by membrane bound ChAT may be due to the 
fact that nerve ending ChAT was separated into soluble (acetylates 
choline but not homocholine, and represents at least 70% of nerve end-
; ng ChAT) and membrane bound ChAT ( acetyl ates cha H ne better than homo-
chol ine and only represents 15% of nerve ending ChAT). 
Both AHCh and ACh compete with choline for binding to ChAT, as 
illustrated by the Dixon plots. The product AHCh is more potent than 
ACh in inhibiting ChAT solubilized from the P3 fraction and ChAT nom-
ionically associated with the P4 fraction. As Cha et al. (1975) have 
suggested, the larger chain analog may become "wedged" in the cata-
lytic site and act as a more potent inhibitor than the natural end 
product. 
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TABLE l. ABILITY OF NVP TO INHIBIT ACETY~ ATION OF CHOLINE, HOMOCHOLINE AND CARNITINE 
BY ChAT SOLUBILIZED FROM A CRUDE VESICULAR FRACTIONa 
CONTROL 
NVP (4.6 uM) 
CHOLINE 
908 + 114 ( 12 ) 
217 + 46 (12)b 
HOMOCHOLINE CARN I TINE 
78 + 22 (12) 136 + 16 (6) 
65 + 24 (12) 123 + 8 ( 6) 
~;·:C-~ 
aAliquots of subcellular fractions were incubated with either 10 mM choline or 10 mM homocholine, 
or 1.2 mM carnitine for 30 min at 39°C, and amounts of acetylated products determined following 
correction for acetylation of endogenous substrates. Results are expressed as nmol of acetylated 
product formed/g wet wt/hr. 
bResults significantly different from control at P< 0.05 (t -test, unpaired). 
N 
~ 
TABLE 2. KINETIC VALUES FOR THE COMPETITIVE ALTERNATIVE SUBSTRATES OF P4 ChAT, CHOLINE AND HOMOCHOLINEa 
Km (choline) 
(uM) 
EXPT. l 123 
EXPT. 2 144 
EXPT. 3 172 
Mean + S.E.M. 146 + 14 
- -
THEORETICAL 
vmax (choline) 
(nmol/g wet wt/hr) 
465 
187 
233 
295 + 86 
-
V'max (homocholine) 
(nmol/g wet wt/hr) 
125 
50 
61 
79 + 23 
s 
(uM) 
45 
52 
61 
52 + 5 
47 
aNormalized values from Expt. 1 and Expt. 2 are illustrated in Fig. 3 and 4. In all three experiments, 
the K and Vmax for choline were determined from line A (0 Homocholine). V'max for homocholine was calcu~ated from the Y-coordinate of the point of intersection (Vmaxlv = V'max• Cha, 1968). S, the cho-
line concentration at which homocholine appears to have no effect, was determined from the X-coordinate 
of the point of intersection (K /S). The theoretical value for S was determined from a plot of the theo-
retical equation m 
Vmax (S) Vmax (S') 
---+----
Km K' m v = ~~~~~~~~~~-
l+ill+~ 
K K1 
m m 
where Km· and V were the means from these three experiments (146 uM and 295 nmol/g wet wt/hr, re-
spectively), aW8xK'm and V'max obtained from Fig. 1 (49 uM and 70 umol/g wet wt/hr, respectively). 
w 
0 
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+ {CH3) N-CH2-CH2-CHz-OH 
Figure 1. The structure of choline and the analog homocholine. 
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Figure 2. Lineweaver-Burk plot of homocholne acetylation of P4 ChAT. 
2 ul aliquots of the P4 fraction were incubated at 39° for 
15 min in the presence of varying concentrations of homo-
chol ine ranging from 1 x 10-5 M to 1 x 10-2 M. Each point 
represents the average velocity for 15 forebrains (each 
forebrain assayed in duplicate), after correction for acet-
ylation of endogenous substrates. The apparent Km and Vmax 
~alues for homocholine acetylation are 49 uM and 70 nmol/g 
wet wt/hr, respectively, as calculated from the least 
squares regression line (Y = 0.00072 x + 0.0147; r = .997). 
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Figure 3. Ability of the ChAT inhibitor NVP to inhibit the acetylation 
of choline and homocholine but not carnitine by the P4 frac-
tion. 2 ul aliquots of the P4 fraction were incubated at 
39° for 30 min in the presence of the substrates indicated 
and the effect of NVP (4.6 uM) determined on the formation 
of acetylated products. Amounts of acetylated products 
formed were corrected for acetylation of endogenous sub-
strates. ( ) = number of experimental animals. An asterisk 
indicates that NVP treatment differs from contra 1 at P < 0. 05 
(t-test, unpaired). 
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Figure 4. Ability of homocholine to serve as an alternative substrate 
to choline for acetylation by P4 ChAT . 2 ul aliquots of 
the P4 fraction were incubated at 39° for 15 min with added 
choline concentrations ranging from 20 to 1000 uM and either 
no added homocholine or with one fixed homocholine concen-
tration (0.5, 1.0, 5.0, or 10.0 mM). Results from two sep-
arate experiments (two forebrains) are included in each plot. 
corresponds to Expt 1 and corresponds to Expt 2; 
see Table 2. Choline concentrations were corrected for 
endogenous choline. Values were normalized by multiplying 
l/v by Vmax for choline and l/S (corrected) by Km for cho-
line for each experiment. Least squares regression lines 
(---) for each homocholine concentration are included along 
with the correlation coefficients (r). Curved lines(~) 
through the data points of different kinetic plots were 
drawn independently. In all cases where homocholine was 
present, polynomial regression analysis indicated that a 
second degree polynomial fit the data point better than a 
straight line. 
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Figure 5. Combined kinetic determinations of P4 ChAT activity as a 
function of added choline in the absence and presence of 
fixed homocholine. Superimposing the individual curves 
shown in Fig. 4 results in the curves intersecting at one 
common point, a result interpreted by Cha (1968) to indi-
cate that both substrates are metabolized by the same en-
zyme. The Y coordinate of the point of intersection is 
3.7, which indicates that the Vmax for P4 ChAT as a function 
of choline exceeds the V'max for P4 ChAT as a function of 
homocholine by 3.7 fold. The X coordinate (2.75) repre-
sents the concentration of choline (48.5 uM) at which homo-
choline, irrespective of its concentration, has no effect 
on the velocity of the total acetylated products being 
formed (Km= 133.5 uM choline/2.75 = S (48.5 uM choline). 
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Figure 6. Ability of homocholine to competitively inhibit choline 
acetylation by soluble ChAT but not serve as a substrate. 
2 ul aliquots of the sodium phosphate buffer wash of the 
P3 fraction were incubated for 15 min at 39° with vary-
ing concentrations of added choline ranging from 50 to 
1200 uM, and in the absence or presence of fixed levels 
of homocholine (2.0, 10.0, 20.0 mM). The least squares 
regression lines and correlation coefficients are as 
follows: 
A (0 homocholine) Y = 1.0007 x + 0.995 
B (2 mM homocholine) Y = 1.350 x + 0.814 
C (10 mM homocholine) Y = 1.470 x + 0.916 
D (20 mM homocholine) Y = 2.024 x + 0.754 
r = 0.94 
r = 0.99 
r = 0.98 
r = 0.99 
Polynomial regression analysis indicated that in all 
cases a straight line fit the data better than a second 
degree polynomial. 
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Figure 7. Ability of ACh and AHCh to inhibit acetylation of choline 
by soluble and P4 ChAT. 2 ul aliquots of sodium phosphate 
buffer wash or the P4 fraction were incubated for 15 min 
at 39° with 1. 1 mM choline and varying concentrations of 
either ACh or AHCh. An asterisk indicates that ACh or 
AHCh treatment differs from control at P< 0.05. 
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Figure 8. Dixon plot of acetylhomocholine inhibition of choline 
acetylation by P4 ChAT. 2 ul aliquots of the P4 frac-
tion were incubated for 15 min at 39° in the presence 
of choline (1. 1 or 4.3 mM) and varying concentrations 
of acetylhomocholine. l/v (choline acetylation) is 
plotted as a function of acetylhomocholine concentra-
tion. Acetylhomocholine did not interfere with the 
extraction of [ 14c] ACh into TPB/3-hept. at the con-
centrations used here. Intersection in the fourth 
quadrant indicates competitive inhibition; Ki= 63 mM. 
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Figure 9. Dixon plot of acetylhomocholine inhibition of choline 
acetylation by soluble ChAT. 2 ul aliquots of the 
sodium phosphate buffer wash were incubated for 15 min 
at 39° in the presence of choline (1. 1 or 4.3 mM) and 
varying concentrations of acetylhomocholine, l/v 
(choline acetylation) is plotted as a function of 
acetylhomocholine concentration. Acetylhomocholine 
did not interfere with the extraction of [ 14C] ACh into 
TPB/3-hept. at the concentrations used here. Inter-
section in the fourth quadrant indicates competitive 
inhibition; Ki = 10 mM. 
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Figure 10. Dixon plot of acetylcholine inhibition of choline acety-
lation by P4 ChAT. 2 ul aliquots of the P4 fraction 
were incubated for 15 min at 39° in the presence of cho-
line (1. l or 4.3 mM} and varying concentrations of 
acetylcholine. l/v (choline acetylation} is plotted as 
a function of acetylcholine concentration. Acetylcho-
1 ine dicl not interfere with extraction of [ 14c] ACh into 
TPB/3-hept. at the concentrations used here. Intersec-
tion in the fourth quadrant indicates competitive inhi-
bition; Ki= 200 mM. 
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